Stratum Corneum Hydration As a Potential Marker of Response to Dupilumab in Atopic Dermatitis®: A Prospective Observational Study
Dermatitis® · 2024
DOI: 10.1089/derm.2023.0176 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Dermatitis®, 2024. Verfasst von Trinidad Montero-Vilchez und 5 weiteren Autor:innen. Beteiligte Einrichtung: From the Dermatology Department, Virgen de las Nieves University Hospital, Granada, Spain. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Dermatology Department, Virgen de las Nieves University Hospital, Granada, Spain.
- Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
- Biochemistry Department, Faculty of Medicine, University of Granada, Granada, Spain.
- Dermatology Department, Faculty of Medicine, University of Granada, Granada, Spain.
ORCID-Profile: Trinidad Montero-Vilchez
Zitieren
APA
Montero-Vilchez, T., Rodriguez-Pozo, J. A., Cuenca-Barrales, C., Sanabria-de-la-Torre, R., Torres-de-Pinedo, J. M., & Arias-Santiago, S. (2024). Stratum Corneum Hydration As a Potential Marker of Response to Dupilumab in Atopic Dermatitis®: A Prospective Observational Study. Dermatitis®. https://doi.org/10.1089/derm.2023.0176
Vancouver
Montero-Vilchez T, Rodriguez-Pozo JA, Cuenca-Barrales C, Sanabria-de-la-Torre R, Torres-de-Pinedo JM, Arias-Santiago S. Stratum Corneum Hydration As a Potential Marker of Response to Dupilumab in Atopic Dermatitis®: A Prospective Observational Study. Dermatitis®. 2024. doi:10.1089/derm.2023.0176
BibTeX
@article{MonteroVilchez2024,
author = {Montero-Vilchez, Trinidad and Rodriguez-Pozo, Juan-Angel and Cuenca-Barrales, Carlos and Sanabria-de-la-Torre, Raquel and Torres-de-Pinedo, Jesus-Manuel and Arias-Santiago, Salvador},
title = {Stratum Corneum Hydration As a Potential Marker of Response to Dupilumab in Atopic Dermatitis®: A Prospective Observational Study},
journal = {Dermatitis®},
year = {2024},
doi = {10.1089/derm.2023.0176}
}
EUVIMED